We are live on ! Find out more
APYX icon

Apyx Medical

48 hedge funds and large institutions have $33.7M invested in Apyx Medical in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

20% more funds holding

Funds holding: 40 → 48 (+8)

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.22% less ownership

Funds ownership: 41.84% → 41.61% (-0.22%)

14% less capital inflows, than outflows

Capital inflows: $1.05M | Capital outflows: $1.22M

Holders
48
Holders Change
+8
Holders Change %
+20%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
10
Reduced
9
Closed
3
Calls
$314K
Puts
–
Net Calls
+$314K
Net Calls Change
-$277K

APYX Hedge Fund Activity: Q3 2025 in Review

48 of the 7,656 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2025, worth a combined $33.7M — down 5.3% from $35.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new APYX positions and 3 closed out — a net gain of 8 holders — while 10 added to existing stakes and 9 trimmed.

The largest buyer was Silverberg Bernstein Capital Management, adding an estimated $190K. The largest seller was Private Advisor Group, cutting an estimated $472K.

  • 48 institutional investors held Apyx Medical (APYX) as of Q3 2025, up from 40 in Q2 2025.
  • Funds reported $33.7M of Apyx Medical stock for Q3 2025, down 5.3% quarter-over-quarter.
  • 11 funds opened new Apyx Medical positions in Q3 2025 and 3 closed out, a net change of +8 holders.
  • The largest Apyx Medical buyer in Q3 2025 was Silverberg Bernstein Capital Management, an estimated $190K added.
  • The largest Apyx Medical seller in Q3 2025 was Private Advisor Group, an estimated $472K sold.

Based on aggregated 13F filings for Q3 2025.